Analysis of the Global In Vitro Diagnostics Market

  • July 2014
  • -
  • Frost & Sullivan
  • -
  • 154 pages

Slowing US and European Markets Demand Alignment with Global Market Needs

Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. The global IVD market size was $47.30 billion in 2013; it is expected to reach $62.63 billion in 2017, at a compound annual growth rate of 7.3%. Because of stagnating mature markets, companies are heavily focused on globalization in emerging economies such as China and Brazil. This research service discusses the IVD segments of immunochemistry, point-of-care testing, molecular diagnostics, clinical microbiology, tissue diagnostics, hematology, hemostasis, and self-monitoring blood glucose.

Executive Summary
-Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry.
-The global IVD market size was $ billion in 2013; it is expected to reach $ billion in 2017, growing at a compound annual growth rate (CAGR) of %.
-Global trends summary:
oThe United States and Western Europe are important markets, representing % of global revenue, but the fast-rising Asia-Pacific market should be part of every IVD company’s long-term strategy.
oDespite challenges in reimbursement and a need for Conformité Européenne (CE) marking reform, the Western Europe market exhibits an upward trajectory.
oThe Asia-Pacific region holds the most next-wave emerging markets, including Indonesia, Vietnam, and the Philippines.
oMore patients with private health plans, and the expansion and modernization of health infrastructure, will sustain growth in Latin America; however, a lack of technology and local manufacturing expertise will modulate growth.
-Segment trends summary:
oChina and Eastern Europe drive the demand for integrated analyzers able to run both clinical chemistry assays and immunoassays.
oSelf-monitoring blood glucose (SMBG) segment growth in emerging markets is severely dampened by slowing growth from reimbursement reductions in Europe and the United States.
oThe broad applicability of point-of-care test (POCT) globally, combined with downward pricing trends enabled by microfluidics integration, support the long-term growth of this segment.
oThe developed US and Western European markets continue to drive molecular diagnostics segment growth rather than the emerging Asia-Pacific and Eastern European markets.
oLaunches of new products, support of an existing installed base, and needs of emerging markets will provide relatively consistent hematology segment growth despite some market uncertainties.
oWhile rapid tests and molecular identification methods are a threat to traditional clinical microbiology methods, new mass spectrometry-based identification may bolster segment growth if favorably adopted.
oNew oral anticoagulant drugs are driving the need for associated laboratory testing and demand for coagulation analyzers.
-Competitive landscape summary
oThe global IVD market is highly fragmented, with the top participants—Roche Diagnostics, Siemens Healthcare, and Abbott Diagnostics—controlling % market share.
oMergers and acquisitions (M&A) continue to be an important competitive strategy to access new technology, expand product offerings, enter emerging markets, or increase market share. Further industry consolidation will occur at a rapid pace as IVD companies are acquired by larger IVD companies, pharmaceutical companies, and even nontraditional healthcare companies.

Key Questions This Study Will Answer
Which segments of the market are growing, how long will they continue to grow, and at what rate?
What primary strategies are competitors employing to sustain growth?
What do the key M&A deals indicate about the market?
What are the drivers and restraints for the global IVD market and for emerging markets?
What percentage does each region contribute to the global IVD market? Which regions are growing the fastest?
Which new technologies following next-generation sequencing (NGS) have the potential to be IVD applications?

Table Of Contents

1. EXECUTIVE SUMMARY

Executive Summary
Executive Summary
Scope and Segmentation
Key Questions This Study Will Answer
Market Engineering Measurements
CEO’s Perspective
Methodology

2. MARKET OVERVIEW

Market Overview
Market Overview—Definitions
Market Segmentation

3. EXTERNAL CHALLENGES: DRIVERS AND RESTRAINTS—TOTAL IVD MARKET

External Challenges: Drivers and Restraints—Total IVD Market
Market Drivers
Drivers Explained
Market Restraints
Restraints Explained
Focus on Emerging Markets—Market Drivers
Focus on Emerging Markets—Market Restraints

4. FORECASTS AND TRENDS—TOTAL IVD MARKET

Forecasts and Trends—Total IVD Market
Market Engineering Measurements
Total IVD Market—Revenue Forecast
Revenue Forecast Discussion

5. MARKET SHARE AND COMPETITIVE ANALYSIS— TOTAL IVD MARKET

Market Share and Competitive Analysis— Total IVD Market
Competitive Analysis—Market Share
Market Share Analysis
Competitive Environment
Competitive Factors—Mergers and Acquisitions

6. IMMUNOCHEMISTRY SEGMENT BREAKDOWN

Immunochemistry Segment Breakdown
Immunochemistry Segment—Overview
Immunochemistry Segment—Market Engineering Measurements
Immunochemistry Segment—Revenue Forecast
Immunochemistry Segment—Revenue Forecast Discussion
Competitive Analysis—Market Share
Immunochemistry Segment—Competitive Environment
Immunochemistry Segment—Installed Base
Immunochemistry Segment—Product Analysis
Immunochemistry Segment—Product List
Immunochemistry Segment—Common Tests

7. SELF-MONITORING BLOOD GLUCOSE SEGMENT BREAKDOWN

Self-monitoring Blood Glucose Segment Breakdown
SMBG Segment—Overview
SMBG Segment—Market Engineering Measurements
SMBG Segment—Revenue Forecast
SMBG Segment—Revenue Forecast Discussion
Competitive Analysis—Market Share
Market Share Analysis
SMBG Segment—Competitive Environment
SMBG Segment—Product List

8. POINT-OF-CARE TESTING SEGMENT BREAKDOWN

Point-of-care Testing Segment Breakdown
POCT Segment—Overview
POCT Segment—Market Engineering Measurements
POCT Segment—Revenue Forecast
POCT Segment—Revenue Forecast Discussion
Competitive Analysis—Market Share
Market Share Analysis
POCT Segment—Competitive Environment

9. MOLECULAR DIAGNOSTICS SEGMENT BREAKDOWN

Molecular Diagnostics Segment Breakdown
Molecular Diagnostics Segment—Overview
Molecular Diagnostics Segment—Market Engineering Measurements
Molecular Diagnostics Segment—Revenue Forecast
Molecular Diagnostics Segment—Revenue Forecast Discussion
Competitive Analysis—Market Share
Market Share Analysis
Molecular Diagnostics Segment—Competitive Environment
Molecular Diagnostics Segment—Tests
Molecular Diagnostics Segment—Product List

10. HEMATOLOGY SEGMENT BREAKDOWN

Hematology Segment Breakdown
Hematology Segment—Overview
Hematology Segment—Market Engineering Measurements
Hematology Segment—Revenue Forecast
Hematology Segment—Revenue Forecast Discussion
Competitive Analysis—Market Share
Market Share Analysis
Hematology Segment—Competitive Environment
Hematology Segment—Installed Base
Hematology Segment—Product List

11. CLINICAL MICROBIOLOGY SEGMENT BREAKDOWN

Clinical Microbiology Segment Breakdown
Clinical Microbiology Segment—Overview
Clinical Microbiology Segment—Market Engineering Measurements
Clinical Microbiology Segment—Revenue Forecast
Clinical Microbiology Segment—Revenue Forecast Discussion
Competitive Analysis—Market Share
Market Share Analysis
Clinical Microbiology Segment—Competitive Environment
Clinical Microbiology Segment—Technology Trends

12. HEMOSTASIS SEGMENT BREAKDOWN

Hemostasis Segment Breakdown
Hemostasis Segment—Overview
Hemostasis Segment—Market Engineering Measurements
Hemostasis Segment—Revenue Forecast
Hemostasis Segment—Revenue Forecast Discussion
Competitive Analysis—Market Share
Market Share Analysis
Hemostasis Segment—Competitive Environment
Hemostasis Segment—Tests
Hemostasis Segment—Product List

13. TISSUE DIAGNOSTICS SEGMENT BREAKDOWN

Tissue Diagnostics Segment Breakdown
Tissue Diagnostics Segment Overview
Tissue Diagnostics Segment—Market Engineering Measurements
Tissue Diagnostics Segment—Revenue Forecast
Tissue Diagnostics Segment—Revenue Forecast by Subsegment
Tissue Diagnostics Segment—Revenue Forecast Discussion
Competitive Analysis—Market Share
Competitive Structure

14. REGIONAL BREAKDOWN

Regional Breakdown
Total IVD Market—Percent Revenue Forecast by Region
Total IVD Market—Regional Growth
IVD Market—US Revenue Forecast
IVD Market—Western Europe Revenue Forecast
IVD Market—Asia-Pacific and China Revenue Forecast
IVD Market—Brazil Revenue Forecast
IVD Market—Eastern Europe Revenue Forecast
IVD Market—Rest of World Revenue Forecast

15. THE LAST WORD

The Last Word
The Last Word—Three Big Predictions
The Last Word—Discussion
Legal Disclaimer

16. APPENDIX

Appendix
List of Other Companies—Total Market Level
List of Other Companies—Segment Level
List of Other Companies—US Tissue Diagnostics Segment
Associated Multimedia
Market Engineering Methodology
Learn More—Next Steps

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 21 100
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $32,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. “2014 Strategies for the Global Microbiology Testing Market” is a new seven-country strategic analysis ...

Enteric Disease Testing and Treatment: Technologies and Global Markets

Enteric Disease Testing and Treatment: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • October 2014
  • by BCC Research

REPORT HIGHLIGHTS The global market for diagnostics and preventive vaccines for enteric diseases reached $6.5 billion in 2013. This market should grow to $10 billion in 2014 and about $21.9 billion in ...

Chemical Separation and Purification: Technologies and Global Markets

Chemical Separation and Purification: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • October 2014
  • by BCC Research

REPORT HIGHLIGHTS BCC Research estimates the total global market for separation and purification equipment reached about $11.2 billion in 2013 and $11.4 billion in 2014. This market is expected to reach ...

Global Immunoassay Systems Market

September 2014 $ 4 950

Global Cholesterol Testing Market

September 2014 $ 4 950

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.